CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594 | +48.5% | 13,087 | +83.7% | 0.00% | +100.0% |
| Q2 2023 | $400 | +70.2% | 7,123 | +37.1% | 0.00% | 0.0% |
| Q1 2023 | $235 | -100.0% | 5,196 | -51.3% | 0.00% | -66.7% |
| Q3 2022 | $698,000 | +3.7% | 10,677 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $673,000 | +6.0% | 10,629 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $635,000 | -19.0% | 10,118 | -2.2% | 0.00% | 0.0% |
| Q4 2021 | $784,000 | -59.4% | 10,348 | -40.1% | 0.00% | -62.5% |
| Q3 2021 | $1,932,000 | -19.1% | 17,262 | +17.1% | 0.01% | -27.3% |
| Q2 2021 | $2,387,000 | +43.8% | 14,743 | +8.2% | 0.01% | +37.5% |
| Q1 2021 | $1,660,000 | +57.3% | 13,625 | +97.7% | 0.01% | +60.0% |
| Q4 2020 | $1,055,000 | +79.1% | 6,893 | -2.2% | 0.01% | +66.7% |
| Q3 2020 | $589,000 | +37.0% | 7,048 | +20.6% | 0.00% | 0.0% |
| Q2 2020 | $430,000 | +91.1% | 5,845 | +10.2% | 0.00% | +50.0% |
| Q1 2020 | $225,000 | -58.3% | 5,304 | -40.1% | 0.00% | -50.0% |
| Q4 2019 | $539,000 | +162.9% | 8,856 | +77.5% | 0.00% | +300.0% |
| Q3 2019 | $205,000 | – | 4,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |